Denali Therapeutics Inc. (DNLI)
Denali Therapeutics Inc. (DNLI) has a 35-report earnings history dating back to Mar 19, 2018. Its average absolute post-earnings move is ±4.89%, and 51.4% of those reactions were positive. Its largest post-earnings gain was +38.25% (Feb 27, 2024) and its largest decline was -10.97% (Feb 27, 2025). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How DNLI moved on each past earnings report.
Earnings Impact
Total Earnings
35
Avg Abs. Movement
±4.89%
Positive %
51.4%
Negative %
48.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☽ POST | +0.1% | open_in_new |
| May 07, 2026 | ☽ POST | -0.61% | open_in_new |
| Feb 26, 2026 | ☽ POST | -1.12% | open_in_new |
| Nov 06, 2025 | ☽ POST | +4.23% | open_in_new |
Earnings Count
35
Total earnings in dataset
Avg Abs. Movement
±4.89%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260904 | open_in_new SEC.gov |
| 4 | 20260904 | open_in_new SEC.gov |
| 4 | 20260903 | open_in_new SEC.gov |
| 144 | 20260902 | open_in_new SEC.gov |
| 144 | 20260901 | open_in_new SEC.gov |
| 4 | 20260814 | open_in_new SEC.gov |
| 4 | 20260813 | open_in_new SEC.gov |
| 144 | 20260811 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
Frequently asked about DNLI earnings
When does Denali Therapeutics Inc. report earnings next? expand_more
Denali Therapeutics Inc. (DNLI)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNLI stock move after earnings? expand_more
Over 35 reports, DNLI has moved an average of ±4.89% the session after earnings, closing higher 51.4% of the time.
What was DNLI's biggest post-earnings move? expand_more
DNLI's largest post-earnings gain on record was +38.25% on Feb 27, 2024, and its largest decline was -10.97% on Feb 27, 2025.
Where can I find Denali Therapeutics Inc.'s SEC filings? expand_more
All of Denali Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right